Seth Demsey reports 20% Corvex stake
Seth Demsey, Co-Chief Executive Officer and director of Corvex, Inc., reports beneficial ownership of 5,540,329 shares of the company’s common stock, representing 20.0% of the 27,635,745 shares outstanding as of July 7, 2026.
Rhea-AI Filing Summary
Seth Demsey, Co-Chief Executive Officer and director of Corvex, Inc., reports beneficial ownership of 5,540,329 shares of the company’s common stock, representing 20.0% of the 27,635,745 shares outstanding as of July 7, 2026. These shares include 5,508,920 held directly and 31,409 held through Ainsworth Holdings, LLC, over which he has sole voting and dispositive power. He also holds additional unvested restricted stock units and unexercisable stock options that are excluded from this 20.0% figure. Demsey received these shares primarily as consideration for Corvex, Inc.’s acquisition of Corvex Legacy Holdings, Inc. and for his executive and board service, giving him significant influence over the company’s governance and strategic direction.
Positive
- None.
Negative
- None.
Insights
Corvex’s Co-CEO now holds a disclosed 20% equity stake.
Seth Demsey, Co-Chief Executive Officer and director of Corvex, Inc., reports beneficial ownership of 5,540,329 common shares, or 20.0% of the company, based on 27,635,745 shares outstanding as of July 7, 2026. This is a sizable block for a single insider.
The filing details that 5,508,920 shares are held directly and 31,409 shares are held via Ainsworth Holdings, LLC, where Demsey has sole voting and dispositive power. Additional equity exposure through 3,054,235 restricted stock units and 2,902,143 stock options is excluded because they will not vest or become exercisable within 60 days.
These holdings largely arose from consideration for the acquisition of Corvex Legacy Holdings, Inc. and compensation for executive and board service. Demsey’s combined ownership and executive role suggest meaningful influence over corporate decisions, including operations and governance matters referenced in the Schedule 13D, though any future actions would depend on decisions not specified in this disclosure.
Key Figures
Key Terms
beneficially owned financial
sole dispositive power financial
restricted stock units financial
stock options financial
Schedule 13D regulatory
Power of Attorney regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Corvex (MOVE) does Seth Demsey’s stake represent?
What control or influence does Seth Demsey have over Corvex (MOVE)?
AI-generated analysis. How Rhea-AI works. Not financial advice.